B{acute over (ø)}nes, Norway

Rolf Berge

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 8 CIPO patents and 1 EPO patent. Top assignee: Atlantic Garden as. Active years: 2012.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rolf Berge: Innovator in Fish Protein Hydrolyzate

Introduction

Rolf Berge is a notable inventor based in Bønes, Norway. He has made significant contributions to the field of nutrition and health through his innovative work with fish protein hydrolyzate. His research focuses on the beneficial effects of enzyme-treated fish protein, which has implications for cardiovascular health.

Latest Patents

Rolf Berge holds a patent for his invention titled "Fish Protein Hydrolyzate." This invention relates to the use of an enzyme-treated fish protein hydrolyzate (FPH). The FPH material is designed to lower the concentration of cholesterol in plasma and triglycerides in the liver. Additionally, FPH induces a favorable change in the fatty acid pattern and lowers the concentration of homocysteine in plasma. A preferable embodiment of the invention relates to the use of FPH as an anti-atherogenic and cardioprotective agent, either administered as a pharmaceutical or as a functional food. He has 1 patent to his name.

Career Highlights

Rolf Berge is associated with Atlantic Garden AS, where he applies his expertise in developing health-oriented products. His work emphasizes the importance of nutrition in promoting overall well-being and preventing chronic diseases.

Conclusion

Rolf Berge's innovative contributions to the field of fish protein hydrolyzate highlight the potential of natural ingredients in enhancing health. His research continues to pave the way for advancements in nutritional science and functional foods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…